Edition:
United States

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

29.45USD
26 Apr 2018
Change (% chg)

$0.03 (+0.10%)
Prev Close
$29.42
Open
$29.57
Day's High
$29.68
Day's Low
$29.20
Volume
1,629,202
Avg. Vol
1,952,188
52-wk High
$29.92
52-wk Low
$24.54

Select another date:

Wed, Apr 25 2018

Heart valve demand helps drive Boston Scientific's forecast

Boston Scientific Corp raised its full-year forecast on Wednesday after reporting stronger-than-expected growth across its businesses, soothing fears that it was losing share in the lucrative market for heart valves.

UPDATE 2-Heart valve demand helps drive Boston Scientific's forecast

* Ramping up production of Acurate heart valves (Adds comments from conf call and analysts, details, updates shares)

BRIEF-Boston Scientific Announces Q1 GAAP Earnings Per Share $0.21

* Q1 EARNINGS PER SHARE VIEW $0.32 -- THOMSON REUTERS I/B/E/S

Medical device maker Boston Scientific posts 10 pct rise in sales

April 25 U.S. medical device maker Boston Scientific Corp reported a 10 percent rise in first-quarter net sales on Wednesday, helped by higher demand for its products, including pacemakers and heart valves.

BRIEF-Boston Scientific Posts Positive Late-Breaking Data From The Intrepid Study

* BOSTON SCIENTIFIC ANNOUNCES POSITIVE LATE-BREAKING DATA FROM THE INTREPID STUDY

BRIEF-Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences

* BOSTON SCIENTIFIC PREVAILS IN EUROPEAN PATENT DISPUTE WITH EDWARDS LIFESCIENCES

BRIEF-Boston Scientific Announces Agreement To Acquire NxThera

* BOSTON SCIENTIFIC CORP - ‍TRANSACTION CONSISTS OF AN UPFRONT CASH PAYMENT OF $306 MILLION​

BRIEF-Late-Breaking Clinical Trial Data Further Demonstrate Safety And Effectiveness Of Rhythmia Mapping System

* LATE-BREAKING CLINICAL TRIAL DATA FURTHER DEMONSTRATE SAFETY AND EFFECTIVENESS OF THE RHYTHMIA™ MAPPING SYSTEM

BRIEF-Boston Scientific Says Acquried EMcision

* BOSTON SCIENTIFIC ANNOUNCES ACQUISITION OF EMCISION, LIMITED

BRIEF-Boston Scientific Completes $1.0 Bln Offering Of Senior Notes

* BOSTON SCIENTIFIC COMPLETES $1.0 BILLION OFFERING OF SENIOR NOTES Source text for Eikon: Further company coverage:

Select another date: